Greenwich LifeSciences, Inc. GLSI
Set alert
17.41 USD -1.59 -8.37%
At close · Oct 30
17.41 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
17.08 Day range 18.77
7.78 52-week range 34.10
- YTD
- -17.13%
- 1 year
- +89.45%
- Open
- 18.47
- Prev close
- 19.00
- Mkt cap
- 255.55M
- Vol
- 174.65K
- Avg vol
- 127.98K
- EPS
- -1.53
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.08
- High
- 18.77
- Forward P/E
- -14.83
- Beta
- 3.32
- Short ratio
- 21.41
- Inst. own
- 8.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 13.57
- 200-d avg
- 14.65
- 1y target
- 38.00
5Y chart
Events in this range
- Apr 10, 2023Rating: HC Wainwright & Co. · — → Buy
- Feb 20, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Feb 28, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Apr 15, 2024Earnings: —; estimate 0; surprise —%
- May 20, 2024Earnings: -0.19; estimate -0.2; surprise 5%
- May 20, 2024Earnings: —; estimate -0.2; surprise —%
- May 22, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 14, 2024Earnings: -0.2; estimate -0.2; surprise 0%
- Aug 14, 2024Earnings: —; estimate -0.2; surprise —%
- Aug 23, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 14, 2024Earnings: -0.2; estimate -0.21; surprise 4.76%
Signals (82)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| RSI: Overbought | Dec 22, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Oct 13, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 13, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| RSI: Oversold | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bearish | Dec 9, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Sep 23, 2024 | 2 years ago |
| SMA: Bullish | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| SMA: Bearish | Jul 29, 2024 | 2 years ago |
| SMA: Bullish | Jul 22, 2024 | 2 years ago |
| SMA: Bearish | Jul 15, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 15, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 24, 2024 | 2 years ago |
| SMA: Bullish | Jun 3, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 29, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| RSI: Overbought | Mar 4, 2024 | 2 years ago |
| SMA: Bullish | Feb 12, 2024 | 2 years ago |
| SMA: Bullish | Feb 12, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 12, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 15, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| SMA: Bearish | Dec 25, 2023 | 2 years ago |
| SMA: Bullish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 7, 2023 | 3 years ago |
| SMA: Bullish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Apr 3, 2023 | 3 years ago |
| SMA: Bullish | Mar 13, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Feb 13, 2023 | 3 years ago |
| RSI: Overbought | Jan 23, 2023 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Oct 24, 2022 | 4 years ago |
| SMA: Bullish | Oct 3, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| RSI: Oversold | Aug 29, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bearish | Jul 18, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| MACD: Buy Signal | Jun 27, 2022 | 4 years ago |
| SMA: Bearish | Mar 28, 2022 | 4 years ago |
| RSI: Oversold | Mar 21, 2022 | 4 years ago |
| SMA: Bullish | Mar 7, 2022 | 4 years ago |
Key statistics
- Market cap
- 159.84M
- Enterprise value
- 171.41M
- Trailing P/E
- 0.00
- Forward P/E
- -14.83
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 23.30
- EPS (TTM)
- -0.81
- Beta
- 3.32
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -3.15M
- Total cash
- 7.22M
- Total debt
- 0
- Return on equity
- -123.67%
- Shares outstanding
- 13.14M
- Short % of float
- 7.83%
- 50-day average
- 13.57
- 200-day average
- 14.65
Analyst view
Consensus: none
Price target (mean) 38.00
Next earnings
Aug 14, 2024
Expected Aug 14, 2024. Consensus EPS estimate 0.00.
Financials — quick view
GLSI Revenue — quarterly 0
GLSI Net income — quarterly -3.95M
GLSI EPS — quarterly -0.27
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | -0.21 | -0.20 | +0.01 | +4.76% |
| Aug 14, 2024 | Jun 1, 2024 | -0.20 | -0.20 | 0.00 | 0.00% |
| Aug 14, 2024 | Jun 1, 2024 | -0.20 | — | — | — |
| May 20, 2024 | Mar 1, 2024 | -0.20 | -0.19 | +0.01 | +5.00% |
| May 20, 2024 | Mar 1, 2024 | -0.20 | — | — | — |
| Apr 15, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 23, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| May 22, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Feb 28, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Feb 20, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Apr 10, 2023 | HC Wainwright & Co. | reit | — | Buy |
| Sep 1, 2021 | HC Wainwright & Co. | init | — | Buy |
About Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- greenwichlifesciences.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on GLSI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| PATEL SNEHAL | Chief Executive Officer | Purchase | Sep 25, 2024 | 5,536,100 |
| THOMPSON JAYE L | Officer | Purchase | Nov 20, 2024 | 264,148 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 2.66% | 350,144 | 4.26M | Sep 29, 2024 |
| Vanguard Group Inc | 2.08% | 273,525 | 3.33M | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.02% | 133,550 | 1.62M | Sep 29, 2024 |
| Credit Agricole S.A. | 0.66% | 87,000 | 1.06M | Sep 29, 2024 |
| Northern Trust Corporation | 0.57% | 74,500 | 905.92K | Sep 29, 2024 |
| State Street Corporation | 0.54% | 71,408 | 868.32K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.17% | 153,459 | 1.87M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.08% | 141,696 | 1.72M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.54% | 71,311 | 867.14K | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.47% | 61,696 | 750.22K | Aug 30, 2024 |
| iShares Russell 2000 Growth ETF | 0.39% | 50,661 | 616.04K | Oct 30, 2024 |
| Fidelity Extended Market Index Fund | 0.25% | 32,217 | 391.76K | Oct 30, 2024 |